--- title: "Assertio 投资者警示：Kahn Swick & Foti, LLC 正在调查拟议出售 Assertio Holdings, Inc. - ASRT 的价格和流程是否合理" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/286953224.md" description: "Kahn Swick & Foti, LLC 正在调查 Assertio Holdings, Inc. (ASRT) 拟议出售给 Garda Therapeutics 的事宜，股东将获得每股 18.00 美元。该公司旨在评估这一价格的合理性及其形成过程，质疑是否低估了该公司。感兴趣的各方可以联系 KSF 获取更多信息" datetime: "2026-05-19T18:17:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286953224.md) - [en](https://longbridge.com/en/news/286953224.md) - [zh-HK](https://longbridge.com/zh-HK/news/286953224.md) --- # Assertio 投资者警示：Kahn Swick & Foti, LLC 正在调查拟议出售 Assertio Holdings, Inc. - ASRT 的价格和流程是否合理 Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Assertio Holdings, Inc. (NasdaqCM: ASRT) to Garda Therapeutics. Under the terms of the proposed transaction, shareholders of Assertio will receive $18.00 per share in cash and a contingent value right. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-asrt/ to learn more. _**Please note that the transaction is structured as a tender offer, such that time may be of the essence.**_ To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn Kahn Swick & Foti, LLC Lewis Kahn, Managing Partner lewis.kahn@ksfcounsel.com 855-768-1857 1100 Poydras St., Suite 960 New Orleans, LA 70163 View source version on businesswire.com: https://www.businesswire.com/news/home/20260519876676/en/ ### 相关股票 - [ASRT.US](https://longbridge.com/zh-CN/quote/ASRT.US.md) ## 相关资讯与研究 - [Assertio 终止了与 Garda 的协议，并同意以 1.664 亿美元被 Zydus Worldwide DMCC 收购](https://longbridge.com/zh-CN/news/286261460.md) - [Garda 将以每股 21.80 美元的价格收购 Assertio](https://longbridge.com/zh-CN/news/285075626.md) - [Select 医药控股、Unifirst、Centessa Pharmaceuticals 和 Assertio 是否为其股东争取到了公平的交易？](https://longbridge.com/zh-CN/news/286972902.md) - [Assertio宣布与Garda Therapeutics修订并重述合并协议](https://longbridge.com/zh-CN/news/285068087.md) - [Assertio 推迟了在待定的 Garda 收购中的要约收购](https://longbridge.com/zh-CN/news/285226139.md)